Aibotics, Inc. financial data

Symbol
AIBT on OTC
Location
480 22 Nd Street, Heyburn, ID
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.08 % -32.9%
Debt-to-equity -132 % +23.8%
Return On Equity 54.8 % -10.5%
Return On Assets -171 % -104%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 441M shares
Common Stock, Shares, Outstanding 319M shares +5717%
Entity Public Float 1.37M USD -11.5%
Common Stock, Value, Issued 319K USD +5717%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 1.87M USD +41%
Operating Income (Loss) -1.87M USD -40.8%
Nonoperating Income (Expense) -231K USD +28%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.1M USD -27.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.1M USD -27.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 241K USD +18.9%
Property, Plant and Equipment, Net 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 776K USD
Assets 1.02M USD -38.1%
Accrued Liabilities, Current 180K USD -60%
Liabilities, Current 4.9M USD -1.98%
Liabilities 4.9M USD -1.98%
Retained Earnings (Accumulated Deficit) -12.4M USD -20.3%
Stockholders' Equity Attributable to Parent -3.89M USD -15.7%
Liabilities and Equity 1.02M USD -38.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.4K USD +61.5%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 467M shares 0%
Common Stock, Shares, Issued 319M shares +5717%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 230K USD +13.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 993K USD +79.9%
Deferred Tax Assets, Gross 993K USD +79.9%
Depreciation 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 442K USD +64.7%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 8.21M USD +18.1%
Interest Expense 137K USD -57.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares